{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:16:02Z","timestamp":1784546162157,"version":"3.55.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":324,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.idcr.2025.e02437","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T16:27:08Z","timestamp":1764001628000},"page":"e02437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis and persistent bacteremia using adjunctive ceftaroline fosamil to vancomycin: A case report"],"prefix":"10.1016","volume":"42","author":[{"given":"Sufyan Mohammed","family":"Alomair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Al","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taef","family":"Khayyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haytham","family":"Wali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Bosaeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.idcr.2025.e02437_bib1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/cid\/cir147","article-title":"Ceftaroline: a novel cephalosporin with activity against methicillin-resistant Staphylococcus aureus","volume":"52","author":"Saravolatz","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idcr.2025.e02437_bib2","unstructured":"U.S. Food & Drug Administration. (2010, O., Drug Approval Package: Teflaro (ceftaroline fosamil) Injection (NDA 200327). Retrieved from."},{"issue":"1","key":"10.1016\/j.idcr.2025.e02437_bib3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12879-019-3791-z","article-title":"Use of ceftaroline fosamil in osteomyelitis: CAPTURE study experience","volume":"19","author":"Johnson","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02437_bib4","doi-asserted-by":"crossref","first-page":"ofab606","DOI":"10.1093\/ofid\/ofab606","article-title":"Multicenter cohort study of ceftaroline versus daptomycin for treatment of methicillin-resistant Staphylococcus aureus bloodstream infection","volume":"9","author":"Zasowski","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02437_bib5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1086\/423145","article-title":"Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein","volume":"190","author":"Fowler","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idcr.2025.e02437_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jclinepi.2017.04.026","article-title":"CARE guidelines for case reports: explanation and elaboration document","volume":"89","author":"Riley","year":"2017","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02437_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijantimicag.2015.04.006","article-title":"Successful treatment of meticillin-resistant Staphylococcus aureus (MRSA) aortic prosthetic valve endocarditis with prolonged high-dose daptomycin plus ceftaroline therapy","volume":"46","author":"Cunha","year":"2015","journal-title":"Int J Antimicrob Agents"},{"issue":"10","key":"10.1016\/j.idcr.2025.e02437_bib8","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline","volume":"36","author":"Sakoulas","year":"2014","journal-title":"Clin Ther"},{"issue":"10","key":"10.1016\/j.idcr.2025.e02437_bib9","doi-asserted-by":"crossref","first-page":"5296","DOI":"10.1128\/AAC.00797-12","article-title":"Addition of ceftaroline to daptomycin after emergence of daptomycin-nonsusceptible Staphylococcus aureus during therapy improves antibacterial activity","volume":"56","author":"Rose","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02437_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s15010-015-0763-0","article-title":"Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature","volume":"43","author":"Baxi","year":"2015","journal-title":"Infection"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02437_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-0034-1396906","article-title":"Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections","volume":"36","author":"Davis","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"39","key":"10.1016\/j.idcr.2025.e02437_bib12","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1093\/eurheartj\/ehad193","article-title":"2023 ESC Guidelines for the management of endocarditis","volume":"44","author":"Delgado","year":"2023","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02437_bib13","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1128\/AAC.00088-14","article-title":"Evaluation of ceftaroline, vancomycin, daptomycin, or ceftaroline plus daptomycin against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus in an in vitro pharmacokinetic\/pharmacodynamic model of simulated endocardial vegetations","volume":"58","author":"Werth","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02437_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/1120009X.2017.1351729","article-title":"Ceftaroline for the treatment of osteomyelitis caused by methicillin-resistant Staphylococcus aureus: a case series","volume":"30","author":"Lalikian","year":"2018","journal-title":"J Chemother"},{"key":"10.1016\/j.idcr.2025.e02437_bib15","article-title":"Adjunctive ceftaroline in combination with daptomycin or vancomycin for complicated methicillin-resistant Staphylococcus aureus bacteremia after monotherapy failure","volume":"6","author":"Hornak","year":"2019","journal-title":"Ther Adv Infect Dis"},{"issue":"44","key":"10.1016\/j.idcr.2025.e02437_bib16","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02437_bib17","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Effect of vancomycin or daptomycin with vs without an antistaphylococcal \u03b2-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","author":"Tong","year":"2020","journal-title":"Jama"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02437_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02483-18","article-title":"Clinical data on daptomycin plus ceftaroline versus standard of care monotherapy in the treatment of methicillin-resistant Staphylococcus aureus Bacteremia","volume":"63","author":"Geriak","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.idcr.2025.e02437_bib19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"},{"issue":"12","key":"10.1016\/j.idcr.2025.e02437_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01293-17","article-title":"A Quasi-experiment to study the impact of vancomycin area under the concentration-time curve-guided dosing on vancomycin-associated nephrotoxicity","volume":"61","author":"Finch","year":"2017","journal-title":"Antimicrob Agents Chemother"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925002938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925002938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T08:36:28Z","timestamp":1767515788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250925002938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":20,"alternative-id":["S2214250925002938"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02437","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis and persistent bacteremia using adjunctive ceftaroline fosamil to vancomycin: A case report","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02437"}}